PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Blizard Institute, Barts and The LondonSchool of Medicine and Dentistry, Queen Mary University of London, and Department of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: simon.tiberi@nhs.net.\', \'Veterans Affairs Medical Center, Washington DC, USA. Electronic address: michael.vjecha1@va.gov.\', \'Blizard Institute, Barts and The LondonSchool of Medicine and Dentistry, Queen Mary University of London, and Department of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: a.zumla@smd18.qmul.ac.uk.\', \'Blizard Institute, Barts and The LondonSchool of Medicine and Dentistry, Queen Mary University of London, and Department of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: j.galvin@smd16.qmul.ac.uk.\', \'Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy. Electronic address: giovannibattista.migliori@fsm.it.\', \'Division of Infection and Immunity, University College London, UK; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK. Electronic address: a.zumla@ucl.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00153-310.1016/j.ijid.2021.02.067
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33713815
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all